RDEA Financial Facts
Basic and diluted net loss per share: -1.25Total operating expenses: 42.49M
See Full Income Statement
Other assets: 1.37M
Accounts payable: 6.93M
See Full Balance Sheet
Earnings History for Ardea Biosciences, Inc. (RDEA)
|
Expand Research on RDEA
| Next EPS Date | 8/6/12 *Est. | EPS Growth Rate | -111.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -29.4% | Revenue Growth Rate | -15.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | -6.7% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/9/12 | Q411 | -$1.15 | -$0.86 | -$0.29 | $1.7M | $1.85M | N/A / N/A | N/A | +56.6% | Details | |
| 5/7/12 | Q112 | -$1.25 | -$0.98 | -$0.27 | $1.5M | $3M | N/A / N/A | N/A | +0.8% | Details | |
11/4/11  |
Q311 | -$0.84 | -$0.67 | -$0.17 | $1.7M | $1.95M | N/A / N/A | N/A | +60.1% | Details | |
| 8/5/11 | Q211 | -$0.68 | -$0.52 | -$0.16 | $2.2M | $2.69M | N/A / N/A | N/A | +59% | Details | |
| 5/6/11 | Q111 | -$0.59 | -$0.50 | -$0.09 | $1.77M | $3.86M | N/A / N/A | N/A | +16.4% | Details | |
| 3/11/11 | Q410 | -$0.03 | -$0.59 | +$0.56 | $17.3M | $4.04M | N/A / N/A | N/A | +22.8% | Details |
